Clinical trials

  • GUSELKUMAB for Crohn's disease
  • Clinical trial in Migraine|Trigeminal nerve disorder
  • TELISOTUZUMAB ADIZUTECAN for Colorectal cancer|Metastatic colorectal cancer
  • CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS for Temporomandibular disorder
  • TAFASITAMAB for Follicular lymphoma | Marginal zone lymphoma
  • TOCILIZUMAB for Sickle cell disease
  • RO7247669 (TOBEMSTOMIG) for Urothelial carcinoma (locally advanced or metastatic)
  • ZANUBRUTINIB for Chronic lymphocytic leukemia | Small lymphocytic lymphoma
  • Trastuzumab for HER2-positive breast cancer | Recurrent ovarian cancer | Solid malignant tumors
  • DURVALUMAB for Non-small cell lung cancer (locally advanced, Stage III, unresectable)
  • PEMBROLIZUMAB for Triple-negative breast cancer | Breast cancer
  • CAMIZESTRANT for Estrogen receptor-positive, HER2-negative advanced breast cancer